soul semaglutide Oral Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the Randomized Trial soul study semaglutide Oral in

Semaglutide is a proven, FDA-approved GLP-1 agonist for weight loss (1520% body weight reduction in clinical trials) Tirzepatide is a dual GIP/GLP-1 agonist showing up to 22% weight loss in trials often more potent than Semaglutide for some patients Retatrutide is an experimental triple agonist with promising early results, but is NOT FDA-approved and not yet available at Better Med Spa All three require medical supervision, lifestyle changes, and ongoing monitoring for safe, sustainable results Better Med Spa in Lincoln Park currently offers Semaglutide and Tirzepatide with physician-directed protocols, slow titration, and holistic wellness integration Quick Comparison: Semaglutide vs

Adult Dehydration

20 In the current study, patients treated with tirzepatide showed consistently greater weight loss compared with semaglutide (Supplemental Figure 2)

Retrieved 10 February 2026

I can see my belt buckle without sucking in